Is Cannabis Inflammatory? Why Context Matters More Than Headlines

Occasionally, a study comes out that challenges what clinicians, researchers, and patients think they know about cannabis and inflammation. One recent retrospective case-control study (Tunagur et al., 2026) looked at inflammatory blood markers in adolescents with cannabinoid use disorder (CUD). The results showed higher inflammatory markers in adolescents using cannabinoids, especially synthetic ones. This has led some people to ask a familiar but overly simple question: Is cannabis pro-inflammatory after all?

A more accurate answer is less dramatic and more helpful: cannabis is not always pro- or anti-inflammatory. Its effects depend on the specific compounds, dose, how it is used, the person’s stage of development, and, most importantly, the state of their endocannabinoid system (ECS).

This difference is important because people often interpret studies based on headlines rather than the bigger picture.

What the Study Actually Shows

The adolescent CUD study measured several blood-based inflammatory ratios, such as neutrophil-to-lymphocyte ratio (NLR), basophil-to-lymphocyte ratio (BLR), and systemic immune-inflammation index (SII). These markers were higher in youth with cannabinoid use disorder compared to healthy controls. The increases were highest in adolescents using synthetic cannabinoids, moderate in those using both synthetic and plant cannabis, and lowest in the group using only cannabis, where only one marker (BLR) was significantly different from controls.

This pattern is important. Synthetic cannabinoids, which are often full CB1 agonists without other plant compounds to balance them, have long been linked to immune activation, toxicity, and dysregulation. Their high inflammatory markers match what previous research has found.

However, it is less clear whether these results actually support the idea that cannabis itself is inflammatory.

Stress Physiology Is Not the Same as Cannabinoid Immunology

Markers like NLR, BLR, and SII are not specific to cannabis. They are sensitive indicators of stress and immune activity in the body. These ratios can increase due to sleep loss, chronic stress, trauma, metabolic strain, anxiety, and problems with the nervous system. These issues are common in adolescents with substance use disorders, no matter which substance they use.

In other words, these results probably reflect overall stress in the body, not inflammation caused only by cannabinoids.

This difference matters even more when we think about the study group. Adolescence is a time when the brain and immune system are still developing. The ECS is not fully mature, stress responses are stronger, and the body’s systems are more easily thrown off balance. Heavy, unpredictable, high-THC use, especially without CBD or other balancing compounds, can make things worse in an already vulnerable system. This does not mean cannabis is always inflammatory; it means context is key.

Research shows that cannabis affects inflammation in clear patterns, not simple rules:

Inflammation-modulating effects are commonly observed

CBD → anti-inflammatory, immunomodulatory
THC (low–moderate, non-chronic use) → often anti-inflammatory, frequently via CB2-related pathways
PEA, beta-caryophyllene, cannflavins → clearly anti-inflammatory through non-CB1 mechanisms
Balanced endocannabinoid tone → supports resolution of inflammation rather than immune suppression

Inflammatory effects are more often associated with

Chronic CB1 overstimulation
Full agonists, particularly synthetic cannabinoids
High-dose, high-stress, developmentally vulnerable use
ECS dysregulation, rather than ECS support

Overall, the most important factors are dose, context, which receptors are affected, and the state of the body, not cannabis alone.

What Gets Lost Without Context

One problem with the study is that it does not include details about the types of cannabinoids used. There is no information on THC dose, CBD content, terpene makeup, or cannabis variety. The study also does not look at baseline ECS function, sleep quality, diet, trauma history, or other substance use. Without these details, it is hard to say if immune changes are due to cannabis itself or the overall health and environment of the users.

When compared to the larger body of research, which now includes hundreds of studies and over a thousand publications on cannabinoids and inflammation, the findings in adolescents do not overturn what we know. Instead, they remind us how easily important details can be overlooked.

Reconciling This with the Broader Evidence

Research shows that cannabis compounds are best described as immunomodulatory, not simply anti-inflammatory or pro-inflammatory. Cannabidiol (CBD) regularly shows anti-inflammatory and immune-balancing effects in many studies. Low to moderate doses of THC, especially when not used often or in stressful situations, often have anti-inflammatory effects through CB2 receptors. Other plant compounds, like beta-caryophyllene, palmitoylethanolamide (PEA), and cannflavins, also show clear anti-inflammatory effects through different pathways.

What tends to cause inflammation is not cannabis itself, but things like long-termCB1 overstimulation, use of full agonists, being developmentally vulnerable, and ongoing stress. Synthetic cannabinoids fit all these risk factors. Well-balanced, regulated plant cannabis usually does not.

View more books by Dr. Uwe

Cannabis for Chronic Pain Relief

Order Now

Endocannabinoid Medicine

Order Now

A More Useful Clinical Framing

The main point is this: Cannabis should be seen as a context-dependent immunomodulator, not as always anti- or pro-inflammatory. Unlike synthetic cannabinoids, which clearly raise inflammation markers, plant cannabis shows little effect on overall inflammation in these adolescents. This suggests that the inflammation seen is more related to stress, usage habits, and problems with the endocannabinoid system than to cannabis itself.

This way of looking at things does not ignore the adolescent study. Instead, it places it in the context of a much larger and more complex biological picture. It also reminds us that, for inflammation, the body’s system is more important than the substance, and the real findings matter more than the headlines.

Tunagur, M.T., Kurt Tunagur, E.M. Synthetic Cannabinoid Use is Associated with Higher Systemic Inflammatory Indices than Cannabis Use in Adolescents. Int J Ment Health Addiction (2026).

Author’s Note: This analysis draws on a continually updated review of pre-clinical and clinical inflammation research involving cannabinoids and endocannabinoid signaling. Readers interested in exploring the broader evidence base can access the CannaKeys Inflammation Research Dashboard here: